Active ingredientTipranavirCat. No. P-T132-001CAS 174484-41-4Family · Pharmaceutical analytical standards
Tipranavir
A non-peptidic HIV protease inhibitor, approved in the United States in 2005 for treatment-experienced patients whose virus is resistant to several protease inhibitors, always given with ritonavir as a booster. This family brings together the active ingredient and labelled standards.
Did you know?While the other protease inhibitors mimic a peptide, tipranavir emerged from a screening of coumarins and dihydropyrones: its core belongs to the same chemical family as the anticoagulant warfarin.
Go to the active ingredient →Active ingredientTipranavirCat. No. P-T132-001CAS 174484-41-4
Isotopically labelledTipranavir-d4Cat. No. P-T132-002CAS 1217819-15-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.